Results 1 - 20 of 34,783 for All Library Resources
Sorted by:
Sorted by:
RelevanceOr hit Enter to replace sort method
- Relevance
- Date-newest
- Date-oldest
- Popularity
- Author
- Title
Show only
- Peer-reviewed Journals (2,303)
| Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
|---|---|---|---|
| 1 |
Material Type: Article
|
|
AZD9291 in EGFR Inhibitor–Resistant Non–Small-Cell Lung CancerThe New England journal of medicine, 2015-04, Vol.372 (18), p.1689-1699 [Peer Reviewed Journal]Copyright © 2015 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1411817 ;PMID: 25923549Full text available |
| 2 |
Material Type: Article
|
|
Osimertinib plus savolitinib in patients with EGFR mutation-positive, MET-amplified, non-small-cell lung cancer after progression on EGFR tyrosine kinase inhibitors: interim results from a multicentre, open-label, phase 1b studyThe lancet oncology, 2020-03, Vol.21 (3), p.373-386 [Peer Reviewed Journal]2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Elsevier Ltd ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(19)30785-5 ;PMID: 32027846Full text available |
| 3 |
Material Type: Article
|
|
Osimertinib in Resected EGFR-Mutated Non–Small-Cell Lung CancerThe New England journal of medicine, 2020-10, Vol.383 (18), p.1711-1723 [Peer Reviewed Journal]Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2027071 ;PMID: 32955177Full text available |
| 4 |
Material Type: Article
|
|
Phase III Randomized Trial of Ipilimumab Plus Etoposide and Platinum Versus Placebo Plus Etoposide and Platinum in Extensive-Stage Small-Cell Lung CancerJournal of clinical oncology, 2016-11, Vol.34 (31), p.3740-3748 [Peer Reviewed Journal]ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.2016.67.6601 ;PMID: 27458307Full text available |
| 5 |
Material Type: Article
|
|
Osimertinib in Pretreated T790M-Positive Advanced Non-Small-Cell Lung Cancer: AURA Study Phase II Extension ComponentJournal of clinical oncology, 2017-04, Vol.35 (12), p.1288-1296 [Peer Reviewed Journal]ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.2016.70.3223 ;PMID: 28221867Full text available |
| 6 |
Material Type: Article
|
|
Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: integrated analysis of three phase 1–2 trialsThe lancet oncology, 2020-02, Vol.21 (2), p.261-270 [Peer Reviewed Journal]2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Elsevier Ltd ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(19)30690-4 ;PMID: 31838015Full text available |
| 7 |
Material Type: Article
|
|
Efficacy and Safety of Patritumab Deruxtecan (HER3-DXd) in EGFR Inhibitor-Resistant, EGFR -Mutated Non-Small Cell Lung CancerCancer discovery, 2022-01, Vol.12 (1), p.74-892021 The Authors; Published by the American Association for Cancer Research. ;2021 The Authors; Published by the American Association for Cancer Research 2021 American Association for Cancer Research ;ISSN: 2159-8274 ;EISSN: 2159-8290 ;DOI: 10.1158/2159-8290.cd-21-0715 ;PMID: 34548309Full text available |
| 8 |
Material Type: Article
|
|
Gefitinib plus chemotherapy versus placebo plus chemotherapy in EGFR -mutation-positive non-small-cell lung cancer after progression on first-line gefitinib (IMPRESS): a phase 3 randomised trialThe lancet oncology, 2015-08, Vol.16 (8), p.990-998 [Peer Reviewed Journal]Elsevier Ltd ;2015 Elsevier Ltd ;Copyright © 2015 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Aug 2015 ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(15)00121-7 ;PMID: 26159065 ;CODEN: LANCAOFull text available |
| 9 |
Material Type: Article
|
|
First-SIGNAL: First-Line Single-Agent Iressa Versus Gemcitabine and Cisplatin Trial in Never-Smokers With Adenocarcinoma of the LungJournal of clinical oncology, 2012-04, Vol.30 (10), p.1122-1128 [Peer Reviewed Journal]2015 INIST-CNRS ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2011.36.8456 ;PMID: 22370314Full text available |
| 10 |
Material Type: Article
|
|
Postoperative Chemotherapy Use and Outcomes From ADAURA: Osimertinib as Adjuvant Therapy for Resected EGFR-Mutated NSCLCJournal of thoracic oncology, 2022-03, Vol.17 (3), p.423-433 [Peer Reviewed Journal]2021 International Association for the Study of Lung Cancer ;Copyright © 2021 International Association for the Study of Lung Cancer. Published by Elsevier Inc. All rights reserved. ;ISSN: 1556-0864 ;EISSN: 1556-1380 ;DOI: 10.1016/j.jtho.2021.10.014 ;PMID: 34740861Full text available |
| 11 |
Material Type: Article
|
|
A Phase 1 study of gefitinib combined with durvalumab in EGFR TKI-naive patients with EGFR mutation-positive locally advanced/metastatic non-small-cell lung cancerBritish journal of cancer, 2021-01, Vol.124 (2), p.383-390 [Peer Reviewed Journal]The Author(s), under exclusive licence to Cancer Research UK 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s), under exclusive licence to Cancer Research UK 2020 ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/s41416-020-01099-7 ;PMID: 33012782Full text available |
| 12 |
Material Type: Article
|
|
Afatinib versus placebo for patients with advanced, metastatic non-small-cell lung cancer after failure of erlotinib, gefitinib, or both, and one or two lines of chemotherapy (LUX-Lung 1): a phase 2b/3 randomised trialThe lancet oncology, 2012-05, Vol.13 (5), p.528-538 [Peer Reviewed Journal]Elsevier Ltd ;2012 Elsevier Ltd ;Copyright © 2012 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited May 2012 ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(12)70087-6 ;PMID: 22452896 ;CODEN: LANCAOFull text available |
| 13 |
Material Type: Article
|
|
Amivantamab plus Chemotherapy in NSCLC with EGFR Exon 20 InsertionsThe New England journal of medicine, 2023-11, Vol.389 (22), p.2039-2051 [Peer Reviewed Journal]Copyright © 2023 Massachusetts Medical Society. ;Copyright © 2023 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2306441 ;PMID: 37870976Full text available |
| 14 |
Material Type: Article
|
|
Lazertinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: results from the dose escalation and dose expansion parts of a first-in-human, open-label, multicentre, phase 1–2 studyThe lancet oncology, 2019-12, Vol.20 (12), p.1681-1690 [Peer Reviewed Journal]2019 Elsevier Ltd ;Copyright © 2019 Elsevier Ltd. All rights reserved. ;2019. Elsevier Ltd ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(19)30504-2 ;PMID: 31587882Full text available |
| 15 |
Material Type: Article
|
|
Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancerNature genetics, 2012-08, Vol.44 (8), p.852-860 [Peer Reviewed Journal]2015 INIST-CNRS ;COPYRIGHT 2012 Nature Publishing Group ;ISSN: 1061-4036 ;EISSN: 1546-1718 ;DOI: 10.1038/ng.2330 ;PMID: 22751098 ;CODEN: NGENECFull text available |
| 16 |
Material Type: Article
|
|
Osimertinib with or without Chemotherapy in EGFR -Mutated Advanced NSCLCThe New England journal of medicine, 2023-11, Vol.389 (21), p.1935-1948 [Peer Reviewed Journal]Copyright © 2023 Massachusetts Medical Society. ;Copyright © 2023 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2306434 ;PMID: 37937763Full text available |
| 17 |
Material Type: Article
|
|
Brigatinib in Crizotinib-Refractory ALK+ NSCLC: 2-Year Follow-up on Systemic and Intracranial Outcomes in the Phase 2 ALTA TrialJournal of thoracic oncology, 2020-03, Vol.15 (3), p.404-415 [Peer Reviewed Journal]2019 International Association for the Study of Lung Cancer ;Copyright © 2020 by the International Association for the Study of Lung Cancer ;Copyright © 2019 International Association for the Study of Lung Cancer. Published by Elsevier Inc. All rights reserved. ;ISSN: 1556-0864 ;EISSN: 1556-1380 ;DOI: 10.1016/j.jtho.2019.11.004 ;PMID: 31756496Full text available |
| 18 |
Material Type: Article
|
|
Recurrence-associated gene signature in patients with stage I non-small-cell lung cancerScientific reports, 2021-10, Vol.11 (1), p.19596-19596, Article 19596 [Peer Reviewed Journal]2021. The Author(s). ;The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 2045-2322 ;EISSN: 2045-2322 ;DOI: 10.1038/s41598-021-99197-w ;PMID: 34599262Full text available |
| 19 |
Material Type: Article
|
|
Outcomes according to initial and subsequent therapies following intracranial progression in patients with EGFR-mutant lung cancer and brain metastasisPloS one, 2020-04, Vol.15 (4), p.e0231546-e0231546 [Peer Reviewed Journal]COPYRIGHT 2020 Public Library of Science ;2020 Hyun et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 Hyun et al 2020 Hyun et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0231546 ;PMID: 32298306Full text available |
| 20 |
Material Type: Article
|
|
Osimertinib Western and Asian clinical pharmacokinetics in patients and healthy volunteers: implications for formulation, dose, and dosing frequency in pivotal clinical studiesCancer chemotherapy and pharmacology, 2016-04, Vol.77 (4), p.767-776 [Peer Reviewed Journal]Springer-Verlag Berlin Heidelberg 2016 ;ISSN: 0344-5704 ;EISSN: 1432-0843 ;DOI: 10.1007/s00280-016-2992-z ;PMID: 26902828Full text available |
Results 1 - 20 of 34,783 for All Library Resources
Sorted by:
Sorted by:
RelevanceOr hit Enter to replace sort method
- Relevance
- Date-newest
- Date-oldest
- Popularity
- Author
- Title
Personalize your results
Refine Search Results
Expand My Results
Show only
- Peer-reviewed Journals (2,303)
Refine My Results
Creation Date
- Before 1980 (32)
- 1980 To 1990 (272)
- 1991 To 2001 (2,520)
- 2002 To 2013 (11,887)
- After 2013 (20,073)
-
More options
New Records
- New From Last Month (87)
- New From Last 3 Month (718)
-
More options
Resource Type
- Patents (31,629)
- Articles (3,146)
- Books (4)
- Reports (3)
- Web Resources (1)
-
More options
Subject
- Electricity (10,547)
- Physics (8,336)
- Transporting (6,736)
- Performing Operations (6,736)
- Basic Electric Elements (5,774)
- Chemistry (5,416)
- Metallurgy (5,416)
- Human Necessities (5,035)
- Calculating (3,590)
- Computing (3,590)
- Counting (3,590)
- Semiconductor Devices (3,321)
- Electric Solid State Devices Not Otherwise Provided For (3,321)
- Electric Communication Technique (3,025)
- Lighting (2,979)
- Weapons (2,979)
- Blasting (2,979)
- Heating (2,979)
- Mechanical Engineering (2,979)
- Hygiene (2,353)
-
More options
Databases
- esp@cenet (31,629)
- KoreaMed Open Access (1,515)
- KoreaMed Synapse (1,276)
- DOAJ Directory of Open Access Journals (1,098)
- PubMed Central (1,096)
- ROAD: Directory of Open Access Scholarly Resources (697)
- GFMER Free Medical Journals (660)
- MEDLINE (248)
- ProQuest Central (226)
- HighWire Press (Free Journals) (65)
- Springer Nature OA Free Journals (61)
- Taylor & Francis Open Access (28)
- ProQuest One Psychology (21)
- Open Access: Nature Open Access (16)
- Wiley-Blackwell Titles (Open access) (13)
- Open Access: Freely Accessible Journals by multiple vendors (7)
- Thieme Connect Journals Open Access (7)
- Public Library of Science (PLoS) Journals Open Access (6)
- Freely Accessible Japanese Titles (ERDB Project) (4)
- Amsterdam UMC - Vrije Universiteit Amsterdam (4)
-
More options
Journal Title
- Bulletin Of The Korean Chemical Society (96)
- Daihan Angwa Haghoi Jabji (107)
- Journal Of Clinical Oncology (74)
- Journal Of Korean Neurosurgical Society (91)
- Journal Of Microbiology And Biotechnology (102)
- Korean Journal Of Anesthesiology (78)
- Korean Journal Of Orthodontics (101)
- The Journal Of The Korean Orthopaedic Association (102)
- The Korean Journal Of Gastroenterology (75)
- Tuberculosis And Respiratory Diseases (103)
-
More options
|
||||
 |
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY |  |
(84-028) 37 755 057 | Feedback |
| 19 Nguyen Huu Tho St. Dist.7, HCM |  |
thuvien@tdtu.edu.vn | ||